5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo

5-Aminoimidazole-4-Carboxamide-1-β- d -Ribofuranoside Causes Acute Hepatic Insulin Resistance In Vivo R. Richard Pencek , Jane Shearer , Raul C. Camacho , Freyja D. James , D. Brooks Lacy , Patrick T. Fueger , E. Patrick Donahue , Wanda Snead and David H. Wasserman From the Department of Molecular P...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes (New York, N.Y.) N.Y.), 2005-02, Vol.54 (2), p.355-360
Hauptverfasser:	PENCEK, R. Richard, SHEARER, Jane, CAMACHO, Raul C, JAMES, Freyja D, LACY, D. Brooks, FUEGER, Patrick T, DONAHUE, E. Patrick, SNEAD, Wanda, WASSERMAN, David H
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoimidazole Carboxamide - administration & dosage Aminoimidazole Carboxamide - analogs & derivatives Aminoimidazole Carboxamide - pharmacology Animals Biological and medical sciences Blood Glucose - drug effects Blood Glucose - metabolism Complications and side effects Cyclic AMP - metabolism Diabetes Diabetes. Impaired glucose tolerance Dogs Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Glucose Clamp Technique Glycolysis - drug effects Hyperinsulinism - blood Infusions, Intravenous Insulin resistance Insulin Resistance - physiology Liver - drug effects Liver - physiology Male Medical sciences Patch-Clamp Techniques Portal Vein - physiology Ribonucleotides - administration & dosage Ribonucleotides - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!